Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14068-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14068-1-AP, RRID:AB_2060390
- Product name
- ARID3A antibody
- Antibody type
- Polyclonal
- Description
- ARID3A antibody (Cat. #14068-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IF, IHC, IP, WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references ARID3A promotes the development of colorectal cancer by upregulating AURKA.
ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2.
High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
Tang J, Yang L, Li Y, Ning X, Chaulagain A, Wang T, Wang D
Carcinogenesis 2021 Apr 30;42(4):578-586
Carcinogenesis 2021 Apr 30;42(4):578-586
ARID3A Positivity Correlated With Favorable Prognosis in Patients With Residual Rectal Cancer After Neoadjuvant Chemoradiotherapy.
Yoon G, Park JY, Kim HJ, Choi GS, Kim JG, Kang BW, Kang MK, Seo AN
Anticancer research 2019 Jun;39(6):2845-2853
Anticancer research 2019 Jun;39(6):2845-2853
Let-7 Represses Carcinogenesis and a Stem Cell Phenotype in the Intestine via Regulation of Hmga2.
Madison BB, Jeganathan AN, Mizuno R, Winslow MM, Castells A, Cuatrecasas M, Rustgi AK
PLoS genetics 2015 Aug;11(8):e1005408
PLoS genetics 2015 Aug;11(8):e1005408
High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
Song M, Kim H, Kim WK, Hong SP, Lee C, Kim H
Annals of surgical oncology 2014 Dec;21 Suppl 4:S481-9
Annals of surgical oncology 2014 Dec;21 Suppl 4:S481-9
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- K-562 cells were subjected to SDS PAGE followed by western blot with 14068-1-AP(ARID3A antibody) at dilution of 1:1500
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of HepG2 cells, using ARID3A antibody 14068-1-AP at 1:50 dilution and Rhodamine-labeled goat anti-rabbit IgG (red). Blue pseudocolor = DAPI (fluorescent DNA dye).
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human colon cancer using 14068-1-AP(ARID3A antibody) at dilution of 1:100 (under 10x lens)
- Sample type
- tissue
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- Immunohistochemical of paraffin-embedded human colon cancer using 14068-1-AP(ARID3A antibody) at dilution of 1:100 (under 40x lens)
- Sample type
- tissue
